Intratumoural immunotherapy Educational session

Rationale for intratumoural immunotherapy (ID 45)

Lecture Time
16:15 - 16:35
Speakers
  • A. Marabelle (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
16:15 - 17:45
Authors
  • A. Marabelle (Villejuif, France)
What’s new in chest tumours Educational session

DOI session (ID 525)

Lecture Time
14:15 - 14:15
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
14:15 - 15:45
What’s new in breast & gynaecological cancers Educational session

Integrative analyses to identify genetic determinants of immune responsiveness in cancer (ID 77)

Lecture Time
16:55 - 17:15
Speakers
  • D. Bedognetti (Didra, Qatar)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
16:15 - 17:45
Authors
  • D. Bedognetti (Didra, Qatar)
Innovative technological development Educational session

ADU-S100 (MIW815), a first-in-class STING agonist (ID 123)

Lecture Time
11:50 - 12:15
Speakers
  • A. Van Elsas (Oss, Netherlands)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
11:00 - 12:30
Authors
  • A. Van Elsas (Oss, Netherlands)
Adoptive T cell therapy Educational session

Adoptive immunotherapy for solid malignancies: Current status, paths forward (ID 13)

Lecture Time
15:30 - 15:50
Speakers
  • C. Klebanoff (New York, United States of America)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
14:30 - 16:00
Authors
  • C. Klebanoff (New York, United States of America)
What’s new in chest tumours Educational session

Immunotherapy combos in NSCLC (ID 36)

Lecture Time
14:35 - 14:55
Speakers
  • S. Peters (Lausanne, Switzerland)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
14:15 - 15:45
Authors
  • S. Peters (Lausanne, Switzerland)
Management of side effects Educational session

DOI session (ID 516)

Lecture Time
09:00 - 09:00
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
09:00 - 10:30
Modern anticancer vaccines Educational session

Prostate cancer vaccines (ID 68)

Lecture Time
15:15 - 15:35
Speakers
  • L. Fong (San Francisco, CA, United States of America)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
14:15 - 15:45
Authors
  • L. Fong (San Francisco, CA, United States of America)
Immuno-oncology: State of the art I Educational session

Arginase inhibition to modulate the TME: Rationale and early clinical experience (ID 104)

Lecture Time
09:10 - 09:30
Speakers
  • S. Ioannidis (Epalinges, Not Applicable, Switzerland)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Authors
  • S. Ioannidis (Epalinges, Not Applicable, Switzerland)
Proffered Paper session III Proffered Paper session

Invited Discussant LBA1 and 50O (ID 487)

Lecture Time
11:30 - 11:45
Speakers
  • J. B. Haanen (Amsterdam, Netherlands)
Session Name
Proffered Paper session III
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
11:00 - 12:30
Authors
  • J. B. Haanen (Amsterdam, Netherlands)
Management of side effects Educational session

Requirements for safely administering combination of ipilimumab + nivolumab (ID 27)

Lecture Time
09:40 - 10:00
Speakers
  • H. Kluger (New Haven, United States of America)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
14.12.2018
Time
09:00 - 10:30
Authors
  • H. Kluger (New Haven, United States of America)
Mini Oral session Mini Oral session

Session DOI (ID 507)

Lecture Time
08:00 - 08:00
Session Name
Mini Oral session
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
08:00 - 09:00